Carisbamate: Difference between revisions

Carisbamate
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 11:21, 15 February 2025

An anticonvulsant drug candidate

Carisbamate is a drug candidate that has been investigated for its potential use as an anticonvulsant medication. It was developed by Johnson & Johnson and has been studied for the treatment of epilepsy and other neurological disorders.

Pharmacology

Carisbamate is believed to exert its effects by modulating neurotransmitter systems in the brain, although its precise mechanism of action is not fully understood. It has been shown to have activity in various animal models of epilepsy, suggesting its potential utility in managing seizures.

Clinical Trials

Carisbamate has undergone several clinical trials to evaluate its safety and efficacy. Initial studies indicated that it might be effective in reducing seizure frequency in patients with partial-onset seizures. However, subsequent trials did not demonstrate sufficient efficacy to warrant approval by regulatory agencies such as the FDA.

Development History

The development of carisbamate began in the early 2000s, with Johnson & Johnson conducting preclinical and clinical studies. Despite promising early results, the drug did not meet the necessary endpoints in later-stage trials, leading to a halt in its development for epilepsy.

Potential Uses

While carisbamate was primarily investigated for epilepsy, there is interest in exploring its effects on other neurological conditions, such as neuropathic pain and bipolar disorder. However, further research is needed to establish its efficacy and safety in these areas.

Chemical Properties

Carisbamate is a carbamate derivative, and its chemical structure is characterized by the presence of two carbamate groups. The molecular formula is C₇H₁₂N₂O₄, and it has a molecular weight of 188.18 g/mol.

Related pages

@@ Line 1: / Line 1: @@
-'''Carisbamate''' is a medication that belongs to the class of drugs known as [[anticonvulsant]]s, which are used primarily for the treatment of [[seizure]] disorders. Carisbamate's mechanism of action, while not fully understood, is thought to involve modulation of [[neurotransmitter]] activity in the brain, thereby stabilizing neuronal membranes and suppressing abnormal electrical activity that leads to seizures.
+{{Short description|An anticonvulsant drug candidate}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| IUPAC_name = (RS)-2-O-carbamoyl-1,2-ethanediol 1-carbamate
+| image = Carisbamate2DACS.svg
+| image_size = 200px
+}}
-==Medical Uses==
+'''Carisbamate''' is a drug candidate that has been investigated for its potential use as an [[anticonvulsant]] medication. It was developed by [[Johnson & Johnson]] and has been studied for the treatment of [[epilepsy]] and other [[neurological disorders]].
-Carisbamate is used in the management and treatment of various types of seizures. It may be prescribed as a monotherapy or in combination with other anticonvulsant medications, depending on the specific seizure type and patient response to therapy. The effectiveness of carisbamate in treating different seizure disorders, including [[partial seizures]], [[generalized seizures]], and [[epilepsy]], has been evaluated in clinical trials, but its use may be limited by its side effect profile and the availability of other anticonvulsant drugs with more established efficacy and safety profiles.
 ==Pharmacology==
-===Mechanism of Action===
+Carisbamate is believed to exert its effects by modulating [[neurotransmitter]] systems in the brain, although its precise mechanism of action is not fully understood. It has been shown to have activity in various animal models of epilepsy, suggesting its potential utility in managing [[seizures]].
-The precise mechanism by which carisbamate exerts its anticonvulsant effects is not fully elucidated. However, it is believed to involve modulation of neurotransmitter systems, including possibly enhancing the inhibitory effects of [[gamma-aminobutyric acid]] (GABA) or reducing the excitatory effects of glutamate. By altering neurotransmitter activity, carisbamate helps to stabilize neuronal membranes and prevent the spread of seizure activity in the brain.
-===Pharmacokinetics===
+==Clinical Trials==
-The pharmacokinetic properties of carisbamate, such as absorption, distribution, metabolism, and excretion, are important for understanding its onset of action, duration of effect, and potential interactions with other medications. Carisbamate is metabolized in the liver and excreted primarily by the kidneys, which may have implications for its use in patients with liver or kidney impairment.
+Carisbamate has undergone several [[clinical trials]] to evaluate its safety and efficacy. Initial studies indicated that it might be effective in reducing seizure frequency in patients with [[partial-onset seizures]]. However, subsequent trials did not demonstrate sufficient efficacy to warrant approval by regulatory agencies such as the [[Food and Drug Administration|FDA]].
-==Adverse Effects==
+==Development History==
-Like all medications, carisbamate can cause side effects, although not everyone experiences them. Common adverse effects include dizziness, headache, fatigue, and nausea. More serious side effects are less common but may include allergic reactions, significant changes in mood or behavior, and potential for increased risk of suicidal thoughts or actions. Monitoring for side effects and adjusting the dosage as necessary is an important part of managing treatment with carisbamate.
+The development of carisbamate began in the early 2000s, with [[Johnson & Johnson]] conducting preclinical and clinical studies. Despite promising early results, the drug did not meet the necessary endpoints in later-stage trials, leading to a halt in its development for epilepsy.
-==Contraindications and Precautions==
+==Potential Uses==
-Carisbamate is contraindicated in patients with known hypersensitivity to the drug. Caution is advised when prescribing carisbamate to patients with a history of psychiatric disorders, liver or kidney impairment, or those who are pregnant or breastfeeding, due to the potential for adverse effects on the fetus or newborn. Drug interactions are also an important consideration, as carisbamate may interact with other medications, altering their effects or increasing the risk of side effects.
+While carisbamate was primarily investigated for epilepsy, there is interest in exploring its effects on other neurological conditions, such as [[neuropathic pain]] and [[bipolar disorder]]. However, further research is needed to establish its efficacy and safety in these areas.
-==Conclusion==
+==Chemical Properties==
-Carisbamate is an anticonvulsant medication with potential utility in the treatment of seizure disorders. Its use must be carefully considered in the context of its side effect profile, potential interactions, and the availability of alternative treatments. Ongoing research and clinical experience will further clarify the role of carisbamate in managing seizures and possibly other neurological conditions.
+Carisbamate is a [[carbamate]] derivative, and its chemical structure is characterized by the presence of two carbamate groups. The molecular formula is C<sub>7</sub>H<sub>12</sub>N<sub>2</sub>O<sub>4</sub>, and it has a molecular weight of 188.18 g/mol.
+==Related pages==
+* [[Anticonvulsant]]
+* [[Epilepsy]]
+* [[Neurological disorder]]
 [[Category:Anticonvulsants]]
-[[Category:Medicinal chemistry]]
+[[Category:Carbamates]]
-{{medicine-stub}}